期刊文献+

急性心肌梗死患者氧化低密度脂蛋白抗体测定的临床意义 被引量:1

原文传递
导出
摘要 目的:探讨急性心肌梗死(AMI)患者血清氧化低密度脂蛋白抗体(anti-ox-LDL)的变化及临床意义。方法:68例AMI患者入院时根据临床情况分为静脉溶栓治疗组(Ⅰ亚组,46例)及非溶栓组(Ⅱ亚组,无溶栓适应证或存在禁忌证者22例),同时测定所有患者入院即刻及1个月后血清血脂及anti-ox-LDL水平,各组间进行比较并与对照组比较。结果:①AMI患者入院时血清anti-ox-LDL较对照组明显增高(P<0.01),1个月后显著降低(P<0.001)达对照组水平;②Ⅰ亚组、Ⅱ亚组患者入院时anti-ox-LDL差异无统计学意义;③Ⅰ亚组患者溶栓成功组(26例)与未成功组(20例)入院时anti-ox-LDL差异无统计学意义;④Ⅱ亚组患者急诊冠状动脉造影梗死相关动脉(IRA)末开通者(13例)入院时血清anti-ox-LDL明显高于IRA开通者(9例)。结论:anti-ox-LDL升高与冠状动脉硬化斑块的不稳定性有关,可能是AMI发作的一个危险因素,自发性血管再通可能与血清anti-ox-LDL降低有关,而溶栓所致血管再通则与此无关。
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第8期494-495,共2页 Journal of Clinical Cardiology
  • 相关文献

参考文献1

二级参考文献7

  • 1[1]Ml M, Gronholdt S, Dalager-Pedersen E F. Coronary atherosclerosis: Determinants of plaque rupture.Eur Heart J, 1998,19(Suppl C):C24-C29.
  • 2[2]Yla-Herttuala S, Palinski W, Rosenfeld M E, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J Clin Invest, 1989,84:1086-1095.
  • 3[3]Kim R S, LaBella F S. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J Lipid Res, 1987,28:1110-1117.
  • 4[4]Arja T E, Outi N, Seppo L, et al. Autoantibodies against oxidized low density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol, 2000,20:204-209.
  • 5[5]Danial S. Lewis a conner memorial lecture-oxidative modification of LDL and atherogenesis.Circulation, 1997,95:1062-1071.
  • 6[6]Wu R, Nityanand S, Berglund L, et al. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol, 1997,17:3159-3163.
  • 7[7]Tetsuo S, Yoshiki N, Mariko F, et al. Inverse relationship between circulating oxidized low density lipoprotein (ox-LDL) and anti-ox LDL antibody levels in healthy subjects. Atherosclerosis, 2000,148:171-177.

共引文献3

同被引文献19

  • 1Leeuwenburgh C, Rasmussen JE, Hsu FF, et al. Massspectrometric quantification of markers for proteinoxidation by tyrosyl radical, copper, and hydroxyl radicalin low density lipoprotein isolated from humanatherosclerotic plaques[J]. J Biol Chem, 1997, 272(6):3520-3526.
  • 2Gensini GG. A more meaningful scoring system fordetermining the severity of coronary heart disease[J]. Am JCardiol, 1983, 51(3): 606.
  • 3Stemme S, Hansson GK. Immune mechanisms inatherogenesis[J]. Ann Med, 1994, 26(3): 141-146.
  • 4Hansson GK, Bondjers G, Bylock A, et al. Ultrastructuralstudies on the localization of IgG in the aortic endotheliumand subendothelial intima of atherosclerotic andnonatherosclerotic rabbits[J]. Exp Mol Pathol, 1980, 33(3):302-315.
  • 5Pederson TR, Olsson AG, Faergeman O, et al. Lipoproteinchanges and reduction in the incidence of major coronaryheart disease events in the Scandinavian SimvastatinSurvival Study(4S)[J]. Circulation, 1998, 97(15):1453-1460.
  • 6Erkkil- AT1, N-rv-nen O, Lehto S, et al. Autoantibodiesagainst oxidized low-density lipoprotein and cardiolipin inpatients with coronary heart disease[J]. ArteriosclerThromb Vasc Biol, 2000, 20(1): 204-209.
  • 7Virella G, Thorpe SR, Alderson NL, et al. Autoimmuneresponse to advanced glycosylation end-products of humanlow density lipoprotein[J]. J Lipid Res, 2003, 44(3):487-493.
  • 8Soto Y, Conde H, Aroche R, et al. Autoantibodies tooxidized low density lipoprotein in relation with coronaryartery disease[J]. Hum Antibodies, 2009, 18(3): 109-117.
  • 9Tsimikas S, Brilakis ES, Lennon RJ, et al. Relationship ofIgG and IgM autoantibodies to oxidized low densitylipoprotein with coronary artery disease and cardiovascularevents[J]. J Lipid Res, 2007, 48(2): 425-433.
  • 10Su J, Georgiades A, Wu R, et al. Antibodies of IgMsubclass to phosphorylcholine and oxidized LDL areprotective factors for atherosclerosis in patients withhypertension[J]. Atherosclerosis, 2006, 188(1): 160-166.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部